Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies. Read more about Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies.
Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. Read more about Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.
High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display. Read more about High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.
Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models. Read more about Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models.
Thirdhand cigarette smoke: factors affecting exposure and remediation. Read more about Thirdhand cigarette smoke: factors affecting exposure and remediation.
Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. Read more about Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain. Read more about Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain.
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. Read more about Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. Read more about Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma.
